Determination of N-n-propylnorapomorphine in serum and brain tissue by gas chromatography-negative ion chemical ionization mass spectrometry.

[1]  J. Neumeyer,et al.  The synthesis of multiple deuterated N-n-propyl-norapomorphine N-(d7) and derivatives , 1988 .

[2]  A. Campbell,et al.  S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system , 1987, Brain Research.

[3]  K. Davis,et al.  Rapid Determination of Apomorphine in Brain and Plasma Using High-Performance Liquid Chromatography , 1984 .

[4]  A. Campbell,et al.  Tissue levels of N-n-propylnorapomorphine after treatment with (−)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors , 1982, Neuropharmacology.

[5]  R. Wilcox,et al.  Apomorphine: bioavailability and effect on stereotyped cage climbing in mice. , 1981, Journal of pharmaceutical sciences.

[6]  W. Garland,et al.  Quantitative selected ion monitoring (QSIM) of drugs and/or drug metabolites in biological matrices. , 1981, Journal of chromatographic science.

[7]  Robert V. Smith,et al.  Determination of Apomorphine in Tablets Using High Performance Liquid Chromatography with Electrochemical Detection , 1981 .

[8]  M. Goldman,et al.  Comparison of high-performance liquid chromatography electrochemical detectors for the determination of aporphines, catecholamines and melatonin , 1980 .

[9]  B. Eriksson,et al.  Determination of apomorphine in plasma and brain tissue by ion-pair extraction and liquid chromatography. , 1979, Journal of chromatography.

[10]  A. Clark,et al.  Rapid method for the determination of apomorphine in plasma using high-performance liquid chromatography. , 1979, Journal of chromatography.

[11]  B. Westerink,et al.  Do neuroleptics prevent the penetration of dopamine agonists into the brain? , 1979, European journal of pharmacology.

[12]  J. Kebabian A SENSITIVE ENZYMATIC‐RADIOISOTOPIC ASSAY FOR APOMORPHINE , 1978, Journal of neurochemistry.

[13]  R. Smith,et al.  Gas chromatographic determination of apomorphine in plasma. , 1977, Journal of chromatography.

[14]  D. Fenimore,et al.  Vapor phase silylation of laboratory glassware , 1976 .

[15]  P. Erhardt,et al.  Thin-layer chromatography of apomorphine and its analogs. , 1976, Journal of chromatography.

[16]  R. Smith,et al.  Gas chromatographic determination of apomorphine in urine and feces. , 1975, Analytical chemistry.

[17]  R. Smith,et al.  Conversion of apocodeine to apomorphine and norapomorphine in rats. , 1974, Journal of pharmaceutical sciences.

[18]  R. Smith,et al.  Gas chromatographic determination of apomorphine O-methyl metabolites in urine. , 1973, Journal of chromatography.

[19]  R. Smith,et al.  Analysis of apomorphine and noraphomorphine in urine by thin-layer chromatographic fluorescence quenching. , 1973, Journal of chromatography.

[20]  A. M. Burkman,et al.  Spectrofluorometric assay of apomorphine in brain tissue. , 1971, Journal of pharmaceutical sciences.

[21]  P. N. Kaul,et al.  Biological disposition of apomorphine. II. Urinary excretion and organ distribution of apomorphine. , 1961, Journal of pharmaceutical sciences.